The burden of invasive pneumococcal disease and the potential for reduction by immunisation

Related Experiment Video

Updated: Sep 28, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Helena K Parsons1, David H Dockrell

  • 1Division of Genomic Medicine, University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK.

International Journal of Antimicrobial Agents
|February 19, 2002
PubMed

Insights

Streptococcus pneumoniae causes serious invasive diseases globally, particularly in young children and the elderly. Immunisation is crucial for preventing pneumococcal infections due to rising antibiotic resistance.

Area of Science:

  • Medical Microbiology
  • Epidemiology
  • Public Health

Background:

  • Streptococcus pneumoniae is a leading cause of invasive bacterial disease worldwide.
  • Disease incidence varies geographically and by age, with highest rates in children under 2 and the elderly.
  • Significant mortality persists despite antimicrobial treatments, underscoring the need for preventative strategies.

Purpose of the Study:

  • To review the global burden of invasive pneumococcal disease (IPD).
  • To identify patient populations at high risk for IPD.
  • To analyze the efficacy and cost-effectiveness of available vaccines.

Main Methods:

  • Literature review of epidemiological data on IPD incidence and mortality.
  • Analysis of risk factors associated with IPD.
  • Evaluation of clinical trial data and economic models on pneumococcal vaccines.

Main Results:

  • IPD affects all age groups, with peaks in the very young and elderly.
  • Penicillin-resistant strains of Streptococcus pneumoniae are emerging globally.
  • Vaccine efficacy studies demonstrate significant reductions in IPD incidence.

Conclusions:

  • Immunisation is a critical public health intervention to prevent invasive pneumococcal disease.
  • Vaccine strategies are cost-effective in reducing disease burden and mortality.
  • Continued surveillance and vaccination are essential to combat IPD.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...